EVENTIDE ASSET MANAGEMENT, LLC
13F Reported Value
ⓘ$7.5B
Holdings
301
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
EVENTIDE ASSET MANAGEMENT, LLC disclosed 301 positions worth $7.5B in its Form 13F-HR for Q2 2026, led by $GH (Guardant Health, Inc.) at 3.9% of the equity portfolio, followed by $LRCX and $XMTR. During the quarter the fund opened 58 new positions and exited 35 — including a new stake in $AVLN and a full exit from $PLD. The portfolio is most concentrated in Healthcare (35.2% of disclosed assets). All figures are sourced directly from EVENTIDE ASSET MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1442891.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 39.0#2,164
Quality
$293.8M1,957,828 sh - 79.4#38
Quality
$291.7M673,431 sh - 48.3#1,732
Quality
$208.4M2,151,845 sh - —
Quality
$203.5M415,039 sh - 35.0
Quality
$146.2M1,248,389 sh - —
Quality
$136.0M68,410 sh - 63.3
Quality
$131.7M490,719 sh - 61.3
Quality
$129.9M599,458 sh - 81.1
Quality
$124.7M106,999 sh - 63.9
Quality
$117.2M103,445 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 39.0#2,164 | $293.8M | 1,957,828 | |
| 79.4#38 | $291.7M | 673,431 | |
| 48.3#1,732 | $208.4M | 2,151,845 | |
| — | $203.5M | 415,039 | |
| 35.0 | $146.2M | 1,248,389 | |
| — | $136.0M | 68,410 | |
| 63.3 | $131.7M | 490,719 | |
| 61.3 | $129.9M | 599,458 | |
| 81.1 | $124.7M | 106,999 | |
| 63.9 | $117.2M | 103,445 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of EVENTIDE ASSET MANAGEMENT, LLC's 301 positions.
Showing top 10 of 301 holdings.
Sector Allocation
Healthcare
$2.6B
Technology
$1.9B
Industrials
$1.4B
Energy
$412.2M
Utilities
$376.8M
Consumer Discretionary
$311.0M
Financials
$248.2M
Materials
$152.6M
Top Holdings — EVENTIDE ASSET MANAGEMENT, LLC (Q2 2026)
Top 150 of 301 disclosed positions (by reported value) from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Guardant Health, Inc. | $293.8M | 3.9% | -17% | 39 | |
| 2 | LAM RESEARCH CORP | $291.7M | 3.9% | -2% | 79.4 | |
| 3 | Xometry, Inc. | $208.4M | 2.8% | -27% | 48.3 | |
| 4 | Trane Technologies plc | $203.5M | 2.7% | +2% | — | |
| 5 | Mirum Pharmaceuticals, Inc. | $146.2M | 1.9% | -11% | 35 | |
| 6 | ASML HOLDING NV | $136.0M | 1.8% | +0% | — | |
| 7 | Targa Resources Corp. | $131.7M | 1.8% | -2% | 63.3 | |
| 8 | OLD DOMINION FREIGHT LINE, INC. | $129.9M | 1.7% | +1% | 61.3 | |
| 9 | GE Vernova Inc. | $124.7M | 1.7% | -20% | 81.1 | |
| 10 | UNITED RENTALS, INC. | $117.2M | 1.6% | +6% | 63.9 | |
| 11 | ARGENX SE | $116.6M | 1.6% | +0% | — | |
| 12 | Scholar Rock Holding Corp | $116.1M | 1.6% | -4% | — | |
| 13 | iRhythm Holdings, Inc. | $104.7M | 1.4% | +16% | 54.8 | |
| 14 | KLA CORP | $100.9M | 1.4% | +756% | 78.6 | |
| 15 | Beta Bionics, Inc. | $98.1M | 1.3% | +5% | 29.8 | |
| 16 | LATTICE SEMICONDUCTOR CORP | $93.5M | 1.3% | +0% | 48.7 | |
| 17 | nVent Electric plc | $90.6M | 1.2% | +2% | — | |
| 18 | GENERAC HOLDINGS INC. | $89.8M | 1.2% | +0% | 54.4 | |
| 19 | Datadog, Inc. | $89.0M | 1.2% | +43% | 71.4 | |
| 20 | Palo Alto Networks Inc | $85.7M | 1.1% | -0% | 65.5 | |
| 21 | ENTERGY CORP /DE/ | $83.9M | 1.1% | +7% | 59.5 | |
| 22 | Vaxcyte, Inc. | $80.2M | 1.1% | +0% | — | |
| 23 | MONOLITHIC POWER SYSTEMS, INC. | $79.7M | 1.1% | -1% | 73.3 | |
| 24 | Vistra Corp. | $79.4M | 1.1% | +1% | 71.9 | |
| 25 | Dell Technologies Inc. | $79.3M | 1.1% | +91% | 71.2 | |
| 26 | Royalty Pharma plc | $77.7M | 1.0% | +5% | — | |
| 27 | Axsome Therapeutics, Inc. | $77.5M | 1.0% | -39% | 40.8 | |
| 28 | TERADYNE, INC | $71.4M | 0.9% | +16% | 77.3 | |
| 29 | HORTON D R INC /DE/ | $71.1M | 0.9% | +1% | 53.6 | |
| 30 | Toast, Inc. | $69.4M | 0.9% | +0% | 69.5 | |
| 31 | QUANTA SERVICES, INC. | $67.1M | 0.9% | +4% | 72.1 | |
| 32 | WILLIAMS COMPANIES, INC. | $66.9M | 0.9% | +8% | 64.3 | |
| 33 | METTLER TOLEDO INTERNATIONAL INC/ | $66.5M | 0.9% | +3% | 67.5 | |
| 34 | INSMED Inc | $62.2M | 0.8% | +7% | 39.4 | |
| 35 | RB GLOBAL INC. | $61.5M | 0.8% | +0% | 67.3 | |
| 36 | Liberty Energy Inc. | $60.6M | 0.8% | -4% | 42 | |
| 37 | BELITE BIO, INC | $60.2M | 0.8% | +9% | — | |
| 38 | DT Midstream, Inc. | $59.8M | 0.8% | +1% | 68.6 | |
| 39 | Kymera Therapeutics, Inc. | $57.8M | 0.8% | -20% | 28.4 | |
| 40 | NASDAQ, INC. | $55.9M | 0.8% | -0% | 76.7 | |
| 41 | SITIME Corp | $55.1M | 0.7% | +0% | 66.1 | |
| 42 | NISOURCE INC. | $55.1M | 0.7% | +1% | 62.6 | |
| 43 | Element Solutions Inc | $54.7M | 0.7% | -2% | 46.2 | |
| 44 | NVIDIA CORP | $54.4M | 0.7% | +6% | 85.9 | |
| 45 | Abivax S.A. | $52.6M | 0.7% | +23% | — | |
| 46 | Vulcan Materials CO | $50.1M | 0.7% | +0% | 63.5 | |
| 47 | O REILLY AUTOMOTIVE INC | $50.0M | 0.7% | +1% | 67.4 | |
| 48 | Trevi Therapeutics, Inc. | $49.6M | 0.7% | +1% | — | |
| 49 | COLLEGIUM PHARMACEUTICAL, INC | $49.3M | 0.7% | -4% | 62.7 | |
| 50 | EASTGROUP PROPERTIES INC | $48.9M | 0.7% | +2% | 68.7 | |
| 51 | APPLIED INDUSTRIAL TECHNOLOGIES INC | $48.6M | 0.7% | +19% | 58.7 | |
| 52 | MBX Biosciences, Inc. | $48.2M | 0.6% | -2% | — | |
| 53 | CYTOKINETICS INC | $48.1M | 0.6% | +18% | 28.1 | |
| 54 | IONIS PHARMACEUTICALS INC | $45.6M | 0.6% | +0% | 23.4 | |
| 55 | Avalyn Pharma Inc. | $45.3M | 0.6% | NEW | — | |
| 56 | Revolution Medicines, Inc. | $42.7M | 0.6% | -13% | — | |
| 57 | STERIS plc | $42.1M | 0.6% | +3% | — | |
| 58 | Bloom Energy Corp | $41.7M | 0.6% | +0% | 66.2 | |
| 59 | Ferguson Enterprises Inc. /DE/ | $41.2M | 0.6% | +2% | 52.2 | |
| 60 | Immix Biopharma, Inc. | $40.1M | 0.5% | +53% | — | |
| 61 | CADENCE DESIGN SYSTEMS INC | $39.1M | 0.5% | +425% | 72.6 | |
| 62 | LOWES COMPANIES INC | $39.0M | 0.5% | +4% | 60.8 | |
| 63 | AXON ENTERPRISE, INC. | $38.9M | 0.5% | -0% | 56.6 | |
| 64 | MongoDB, Inc. | $38.6M | 0.5% | +84% | 68.8 | |
| 65 | Celldex Therapeutics, Inc. | $38.6M | 0.5% | +0% | 8.4 | |
| 66 | FASTENAL CO | $38.5M | 0.5% | +1% | 66.9 | |
| 67 | Frontdoor, Inc. | $37.7M | 0.5% | +0% | 60.3 | |
| 68 | Talen Energy Corp | $37.5M | 0.5% | -17% | 57.2 | |
| 69 | KESTRA MEDICAL TECHNOLOGIES, LTD. | $36.8M | 0.5% | +0% | — | |
| 70 | TransMedics Group, Inc. | $36.5M | 0.5% | +0% | 67.2 | |
| 71 | PALVELLA THERAPEUTICS, INC. | $35.4M | 0.5% | -1% | — | |
| 72 | Apogee Therapeutics, Inc. | $34.5M | 0.5% | -53% | — | |
| 73 | COMFORT SYSTEMS USA INC | $34.4M | 0.5% | +97% | 77.7 | |
| 74 | DEXCOM INC | $33.6M | 0.5% | +1% | 76 | |
| 75 | Definium Therapeutics, Inc. | $33.4M | 0.5% | +3% | — | |
| 76 | BridgeBio Pharma, Inc. | $32.6M | 0.4% | +0% | 36.9 | |
| 77 | ROLLINS INC | $32.1M | 0.4% | +2% | 65 | |
| 78 | HOULIHAN LOKEY, INC. | $32.0M | 0.4% | +1% | 67.8 | |
| 79 | Ovid Therapeutics Inc. | $31.8M | 0.4% | +19% | 26.4 | |
| 80 | Nurix Therapeutics, Inc. | $31.5M | 0.4% | +0% | 6.4 | |
| 81 | Vertiv Holdings Co | $30.8M | 0.4% | -3% | 81 | |
| 82 | COHERENT CORP. | $30.6M | 0.4% | +109% | 58.5 | |
| 83 | FIFTH THIRD BANCORP | $30.5M | 0.4% | +1266% | 63.2 | |
| 84 | ARROWHEAD PHARMACEUTICALS, INC. | $30.2M | 0.4% | +0% | 38.7 | |
| 85 | Remitly Global, Inc. | $29.9M | 0.4% | NEW | 72.5 | |
| 86 | MSCI Inc. | $29.4M | 0.4% | +3% | 75.7 | |
| 87 | HUNTINGTON BANCSHARES INC /MD/ | $29.2M | 0.4% | -35% | 65 | |
| 88 | Disc Medicine, Inc. | $28.9M | 0.4% | +0% | — | |
| 89 | UL Solutions Inc. | $28.6M | 0.4% | +5% | 65.2 | |
| 90 | ROCKWELL AUTOMATION, INC | $27.9M | 0.4% | +1% | 63.6 | |
| 91 | Chewy, Inc. | $27.8M | 0.4% | +0% | 56.3 | |
| 92 | TD SYNNEX CORP | $27.0M | 0.4% | NEW | 58.4 | |
| 93 | CG Oncology, Inc. | $26.3M | 0.3% | -0% | 27 | |
| 94 | Baker Hughes Co | $25.6M | 0.3% | +5% | 60.7 | |
| 95 | Waste Connections, Inc. | $25.4M | 0.3% | -51% | 68.2 | |
| 96 | INTUITIVE SURGICAL INC | $24.1M | 0.3% | +1% | 79.9 | |
| 97 | SHERWIN WILLIAMS CO | $24.1M | 0.3% | -1% | 61.3 | |
| 98 | Amylyx Pharmaceuticals, Inc. | $23.8M | 0.3% | -12% | 8.7 | |
| 99 | IDEX CORP /DE/ | $23.5M | 0.3% | +3% | 60.9 | |
| 100 | Oruka Therapeutics, Inc. | $22.8M | 0.3% | NEW | — | |
| 101 | Seagate Technology Holdings plc | $22.8M | 0.3% | +9% | — | |
| 102 | Motorola Solutions, Inc. | $22.4M | 0.3% | +3% | 71.8 | |
| 103 | Dianthus Therapeutics, Inc. /DE/ | $22.0M | 0.3% | +0% | 22.6 | |
| 104 | MARTIN MARIETTA MATERIALS INC | $21.6M | 0.3% | +1186% | 62.9 | |
| 105 | WEC ENERGY GROUP, INC. | $21.1M | 0.3% | -14% | 60.1 | |
| 106 | GLAUKOS Corp | $21.0M | 0.3% | +0% | 40.5 | |
| 107 | Credo Technology Group Holding Ltd | $20.9M | 0.3% | +2767% | 55.1 | |
| 108 | Sionna Therapeutics, Inc. | $20.9M | 0.3% | -26% | — | |
| 109 | MICRON TECHNOLOGY INC | $20.9M | 0.3% | +2% | 86.2 | |
| 110 | Broadcom Inc. | $20.8M | 0.3% | -6% | 84.5 | |
| 111 | Celcuity Inc. | $20.6M | 0.3% | -19% | — | |
| 112 | Arthur J. Gallagher & Co. | $19.9M | 0.3% | +4% | 71.2 | |
| 113 | SUTRO BIOPHARMA, INC. | $19.4M | 0.3% | -18% | 15.3 | |
| 114 | Constellation Energy Corp | $19.3M | 0.3% | -1% | 59.4 | |
| 115 | Privia Health Group, Inc. | $19.0M | 0.3% | +0% | 60.1 | |
| 116 | Heartflow, Inc. | $18.7M | 0.3% | -16% | 34.3 | |
| 117 | GeneDx Holdings Corp. | $18.5M | 0.3% | -41% | 35.4 | |
| 118 | Spyre Therapeutics, Inc. | $17.9M | 0.2% | NEW | — | |
| 119 | EyePoint, Inc. | $17.8M | 0.2% | +0% | 3.5 | |
| 120 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $17.5M | 0.2% | -7% | — | |
| 121 | Rubrik, Inc. | $17.4M | 0.2% | +1765% | 56.6 | |
| 122 | BLACK HILLS CORP /SD/ | $17.2M | 0.2% | NEW | 53.3 | |
| 123 | Aktis Oncology, Inc. | $16.3M | 0.2% | +0% | — | |
| 124 | GARMIN LTD | $16.2M | 0.2% | -4% | — | |
| 125 | Evommune, Inc. | $16.1M | 0.2% | +0% | 14.9 | |
| 126 | WILLIS TOWERS WATSON PLC | $15.9M | 0.2% | -4% | — | |
| 127 | NXP Semiconductors N.V. | $15.8M | 0.2% | NEW | — | |
| 128 | ADVANCED MICRO DEVICES INC | $15.0M | 0.2% | +59% | 79.8 | |
| 129 | Diamondback Energy, Inc. | $15.0M | 0.2% | +24% | 76.1 | |
| 130 | HOME DEPOT, INC. | $14.9M | 0.2% | +24% | 60.3 | |
| 131 | UNITED THERAPEUTICS Corp | $14.7M | 0.2% | -5% | 71.3 | |
| 132 | ACHIEVE LIFE SCIENCES, INC. | $14.5M | 0.2% | NEW | — | |
| 133 | CIENA CORP | $14.5M | 0.2% | +637% | 72.9 | |
| 134 | CATERPILLAR INC | $13.8M | 0.2% | +13% | 66.5 | |
| 135 | AMGEN INC | $13.8M | 0.2% | +33% | 79.2 | |
| 136 | Kailera Therapeutics, Inc. | $13.6M | 0.2% | NEW | — | |
| 137 | PENTAIR plc | $13.6M | 0.2% | -32% | — | |
| 138 | Xylem Inc. | $13.5M | 0.2% | +0% | 65.8 | |
| 139 | Praxis Precision Medicines, Inc. | $13.0M | 0.2% | +0% | — | |
| 140 | RELMADA THERAPEUTICS, INC. | $12.9M | 0.2% | +121% | — | |
| 141 | HALLIBURTON CO | $12.8M | 0.2% | -34% | 53.2 | |
| 142 | LITHIA MOTORS INC | $12.7M | 0.2% | +3% | 46.6 | |
| 143 | Lumentum Holdings Inc. | $12.6M | 0.2% | -1% | 44.3 | |
| 144 | Tango Therapeutics, Inc. | $12.5M | 0.2% | NEW | 17.6 | |
| 145 | LINDE PLC | $11.6M | 0.1% | +9% | — | |
| 146 | ServiceTitan, Inc. | $11.5M | 0.1% | +0% | 49.2 | |
| 147 | EXXON MOBIL CORP | $11.3M | 0.1% | +31% | 57.9 | |
| 148 | Medtronic plc | $11.1M | 0.1% | +22% | 68.7 | |
| 149 | GROUP 1 AUTOMOTIVE INC | $11.0M | 0.1% | -12% | 54.1 | |
| 150 | INTERNATIONAL PAPER CO /NEW/ | $10.8M | 0.1% | -56% | 52.1 |
New Positions (58)
Exited Positions (35)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for EVENTIDE ASSET MANAGEMENT, LLC including:
Track EVENTIDE ASSET MANAGEMENT, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for EVENTIDE ASSET MANAGEMENT, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: EVENTIDE ASSET MANAGEMENT, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For EVENTIDE ASSET MANAGEMENT, LLC (SEC CIK: 1442891), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in EVENTIDE ASSET MANAGEMENT, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.